Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $503,225 - $703,086
11,526 Added 2.02%
581,589 $31.3 Million
Q2 2022

Aug 12, 2022

BUY
$28.82 - $77.35 $12 Million - $32.1 Million
414,721 Added 266.97%
570,063 $23 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $7.5 Million - $15.6 Million
155,342 New
155,342 $10.3 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.82B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.